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ABSTRACT 
Objective:  To determine the outcome of endoscopic assisted microsurgery for pituitary tumors in terms of gross 
tumor removal and visual field improvement. 
Materials and Methods:  This Descriptive case series conducted at Department of Neurosurgery, Lahore General 
Hospital Lahore over a period of six months from July 2012 to December 2012. Sixty five patients were included 
through non-probability purposive sampling technique. All cases of pituitary tumor diagnosed on MRI/CT scan of 
either gender having age 18 – 80 years and patients with recurrent cases, sellar and with suprasellar extension 
(assessed on CT and MRI findings). Informed consent was taken from the patients. All laboratory tests were done 
in hospital laboratory and reported by hospital pathologist Shaukat Khanum Memorial Hospital Lahore. Pre- and 
post-operative visual field status (at least 3 months after surgery) was analyzed. Surgery was performed by a 
single team of surgeons. Surgical procedure involves introduction of 4-mm to 2.7mm endoscope to visualize the 
sphenoethmoid recess. The bilateral sphenoid Ostia are entered. The posterior nasal septum was incised at 
middle turbinate and it was patients resected. All the data was entered and analyzed by using SPSS 20.  Fre-
quency and percentages were calculated for all qualitative variables like gross removal rate and visual filed 
improvement. 
Results:  The mean age of the patients was 50.46 ± 17.80 years. There were 64.62% male patients and 35.38% 
female patients. Gross removal of tumor was observed in 56 (86.2%) and visual field improvement was found in 
92.31% patients. 56 patients were those in which gross removal of tumor was observed in which 34 were males 
and 22 were females, similarly in 9 patients them was subtotal resection of tumor in which 8 were males and only 
1 was female. 
Conclusion:  In this study, gross removal of tumor as well as visual field improvement was found in maximum 
number of patients and it is concluded that endoscopic assisted microsurgery for pituitary tumors is a better 
technique for such surgeries. 
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INTRODUCTION 
Pituitary tumors are abnormal growths that develop in 
our pituitary gland. Some pituitary tumors cause exce-
ssive production of hormones that regulate important 
functions of our body. Other pituitary tumors can res-
trict normal functions of our pituitary gland, causing it 
to produce lower levels of hormones.
1,2
 
 Estimates of the prevalence of pituitary adenomas 
are variable, and are often based upon autopsy or MRI 
series.
3
 According to other epidemiological studies, 
the prevalence of pituitary adenomas is 16.5% and the 
majority of them are incidentalomas.
4
 
 Most pituitary adenomas exceed 10 mm in size 
and have an estimated prevalence of 16.7% (14.4% in 
autopsy studies and 22.5% in radiologic studies).
5
 
Pituitary tumors are usually benign but are associated 
with substantial morbidity. Their etiology is largely 
unknown.
5
 
 The symptoms of pituitary disorders are often 
non-specific; disturbances of pituitary function, com-
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pression symptoms, hypophysis apoplexy or accident-
tal findings may help the diagnosis.
4
 In a series analy-
zing 40 cases of pituitary apoplexy, the presenting 
signs and symptoms included headache (63%), vomit-
ing (50%), visual field defects (61%), ocular paresis 
(40%), mental deterioration (13%), hyponatremia 
(13%), and syncope (5%); in only four cases pituitary 
tumor was diagnosed prior to presentation.
6
 
 Treatment of pituitary tumor depends on the type 
and size of the tumor, whether the tumor is making 
hormones, whether the tumor is causing problems 
with vision or other symptoms, whether the tumor has 
spread into the brain around the pituitary gland or to 
other parts of the body and whether the tumor has just 
been diagnosed or has recurred.
4
 
 Surgical resection is usually successful in remov-
ing the bulk of the tumor, resulting in improvement in 
visual disturbance.
7
 Endoscopic microsurgery has 
remained the primary treatment for most patients with 
non-functioning pituitary microadenomas or function-
ing microadenomas.
8
 
 Endonasal endoscopy is a promising minimally 
invasive surgery for the treatment of pituitary adeno-
mas; it is also a good alternative to traditional subla-
bial or endonasal microsurgery. With visual field 
improvement in 62% of patients.
9
 After endonasal 
endoscopic surgery according to Cappabianca et al. 
the gross tumor removal rate was 62%.
10
 
 On the other hand a recent Meta-analysis also 
reported, among patients who underwent endoscopic 
surgery and were followed for periods ranging from 3 
months to 6 months the reported rate of visual field 
improvement 92% of patients and gross tumor remo-
val rate was 89%.
11
 In a local study there was impro-
vement in visual field was noted in 74% of cases.
12
 
 The rationale of this study is to see the outcome of 
endoscopic assisted microsurgery for pituitary tumors 
in our population. We conduct this study so that we 
can generate local data not only for visual field impro-
vement but also for gross tumor removal. Moreover 
also a huge variation of gross tumor removal (62% 
and 89%)
13,14
 and visual field improvement (62% and 
92%) is available in literature internationally.
10,13
 
 
PATIENTS AND METHODS 
This descriptive case series study conducted at Depa-
rtment of Neurosurgery, Lahore General Hospital 
Lahore over a period of six months from July 2012 to 
December 2012. Sixty five patients were included 
through Non probability purposive sampling techni-
que. All cases of pituitary tumor diagnosed on MRI/ 
CT scan of either gender having age 18 – 80 years and 
patients with recurrent cases, sellar and with supra-
sellar extension (assessed on CT and MRI findings). 
All laboratory tests were done in hospital laboratory 
and reported by hospital pathologist. Pre- and post-
operative visual field status (at least 3 months after 
surgery) was analyzed. Surgery was performed by a 
single team of surgeons. Surgical procedure involves 
introduction of 4-mm to 2.7mm endoscope to visua-
lize the sphenoethmoid recess. The bilateral sphenoid 
Ostia are entered. The posterior nasal septum is inci-
sed and resected. 
 All the data was entered and analyzed by using 
SPSS 20. Mean and standard deviation was calculated 
for quantitative variable like age. Frequency and per-
centages were calculated for qualitative variables like 
gender, gross removal rate and visual filed improve-
ment. 
 
RESULTS 
The mean age of the patients was 50.46±17.80 years 
with minimum and maximum ages of 19 and 79 years 
respectively. In this study 64.62% patients were males 
whereas 35.38% patients were females. Gross removal 
of tumor was observed in 56 (86.2%) patients and it 
subtotal removal was not observed in 9 (13.8%) pati-
ents. The visual field improvement was found in 
92.31% patients and it was not found in 7.69% pati-
ents. There were 56 patients in which gross removal 
of tumor was observed of that 34 were males and 22 
were females, similarly in 9 patients with subtotal 
removal of tumor there were 8 males and only 1 fem-
ale. Statistically insignificant difference was found 
between the gross removal rate and sex of the patients 
i.e. p-value = 0.14. The study showed that visual field 
improvement was found in 60 patients in whom 38 
patients were males and 22 were females, similarly 
visual field improvement was not found in 5 patients 
in which 4 were males and only 1 was female. Statis- 
 
Table 1: Distribution of patients by gross tumor 
removal according to sex (n = 65). 
 
Gross Tumor Removal Male Female Total 
Yes 34 22 56 
No   8   1   9 
Total 42 23 65 
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tically there is insignificant difference was found bet-
ween the visual improvement and sex of the patients 
i.e. p-value = 0.45. 
 
Table 2: Distribution of patients by visual field imp-
rovement according to sex (n = 65). 
 
Gross Field Improvement Male Female Total 
Yes  38 22 60 
No   4   1   5 
Total 42 23 65 
 
DISCUSSION 
Endoscopic endonasal trans-sphenoidal surgery is 
indicated in sellar and suprasellar tumors.
15-17
 Staged 
or combined endoscopic trans-sphenoidal-transventri-
cular approach for resection of a giant pituitary ade-
noma with ventricular extension can achieve a gross 
total removal.
18-20
 
 Endoscopic endonasal transposition of the pitu-
itary gland and its stalk can provide a valuable cor-
ridor to the retroinfundibular tumor.
21
 Endoscopic sur-
gery is a better technique in removal of a suprasellar 
tumor than the microscopic approach due to the better 
visualization.
22
 
 A recent population study from Belgium found a 
prevalence of clinically relevant pituitary adenomas of 
94 per 100,000. Of this group, 66% were prolacti-
nomas, 14.7% were not endocrine – active, 13.2% had 
acromegaly, 5.9% had Cushing’s disease, and 20.6% 
had hypopituitarism.
23
 
 In our study gross removal of tumor was observed 
in 86.2% and visual field improvement was found in 
7.69% patients. Different authors showed the follow-
ing results related to our study results. In a recent 
paper Schramm and coworkers published the results 
of visual outcome in patients with pituitary adenomas 
and preoperative chiasma syndrome, according to 
them the syndrome completely regressed in 42.9%, 
improved in 38.3%, remained unchanged in 11.2% 
and worsened in 7.4% of the patients postopera-
tively.
24
 
 Sanai and colleagues reported results using the 
direct, endonasal approach (using the operating micro-
scope) in 64 patients with challenging pituitary tum-
ors. These included large macroadenomas (> 3cm dia-
meter), tumors with cavernous sinus invasion, and cra-
niopharyngiomas, they reported complete removal in 
49% and near gross total removal in 9%. Of those pat-
ients who presented with visual deficits, 81% showed 
improvement post-operatively.
25
 
 Zhang and colleagues reported results using the 
purely endoscopic, endonasal approach in 78 patients 
with invasive pituitary adenomas (including 11 micro-
adenomas). They achieved complete removal in 
79.5% of patients and improvement in visual symp-
toms in 96.4% of cases.
26
 
 Dehdashti and colleagues reported their outcomes 
in 200 consecutive patients with removal of pituitary 
adenomas using the purely endoscopic, endonasal 
technique. They reported gross total resection in 91% 
of cases overall. This improved to 96 – 98% if tumors 
that invaded the cavernous sinus were excluded. Vis-
ual improvement occurred in 89% of patients.
27
 
 As discussed in literature, after end nasal endo-
scopic surgery According to Cappabianca et al. the 
gross tumor removal rate was 62%.
10
 
 On the other hand a recent Meta-analysis also 
reported, among patients who underwent endoscopic 
surgery and were followed for periods ranging from 3 
months to 6 months the reported rate of visual field 
improvement 92% of patients and gross tumor remo-
val rate was 89%.
11
 In a local study there was impro-
vement in visual field was noted in 74% of cases.
12
 
 Ammirati et al, recently reported a meta-analysis 
concluding that endoscopic removal of pituitary ade-
noma, in the short term, does not seem to confer any 
advantages over the microscopic technique and the 
incidence of vascular complications was higher with 
endoscopic than with microscopic removal of pituitary 
adenomas.
28
 
 Rotenberg et al, concluded that the two approa-
ches had similar outcomes (GTR, hormonal abnor-
mality resolution) but that the endoscopic approach 
was associated with fewer complications as well as a 
shorter hospital stay and length of operation.
29
 
 Mirian Cabral Moreira de Castro and co reported 
that the endoscopic transsphenoidal approach to sellar 
tumors proved to be safe when the majority of the 
tumors were non-secreting. The most frequent com-
plication was CSF leakage.
30
 
 Recent studies have shown endoscopic techniques 
to be associated with similar or reduced rates of com-
plications compared with microsurgical techni-
ques.
14,31,32 
 
CONCLUSION 
In this study, gross removal of tumor as well as visual
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field improvement was found in maximum number of 
patients and it is concluded that endoscopic assisted 
microsurgery for pituitary tumors is a better technique 
for such surgeries. 
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